Integrated Wealth Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
BIT
BFA
Integrated Wealth Counsel's ABBV Position: Q4 2016 in Review
Integrated Wealth Counsel reduced its AbbVie (ABBV) stake by 0.37% in Q4 2016, selling an estimated $1.16K and leaving 5,175 shares worth $324K. The position accounts for 0.7% of the portfolio, ranked #25.
Integrated Wealth Counsel first reported a position in ABBV in Q2 2013 and has held it in 15 quarters since. The position peaked at $555K in Q4 2015. 1,692 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.
- Integrated Wealth Counsel held 5,175 shares of AbbVie worth $324K as of Q4 2016.
- Integrated Wealth Counsel sold 19 AbbVie shares in Q4 2016, an estimated $1.16K.
- AbbVie made up 0.7% of Integrated Wealth Counsel's portfolio in Q4 2016, its #25 holding.
- Integrated Wealth Counsel first reported a position in AbbVie in Q2 2013 and has held it in 15 quarters since.
- Integrated Wealth Counsel's AbbVie position peaked at $555K in Q4 2015.
- 1,692 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.
Based on Integrated Wealth Counsel's 13F filing for Q4 2016, filed 6 Feb 2017.